期刊文献+

乙酮可可碱对大鼠肝脏缺血/再灌注损伤影响的实验研究

The Effect of Pentoxifylline on Hepatic Ischemia and Reperfusion Injury in Rats
下载PDF
导出
摘要 目的探讨乙酮可可碱保护大鼠肝缺血/再灌注损伤的机制。方法采取大鼠第一肝门阻断的缺血再灌注模型,将健康雄性SD大鼠64只随机分为四组:对照组及乙酮可可碱给药组,观察每组动物的病理切片,分别检测血浆谷丙转氨酶(ALT)、乳酸脱氢酶(LDH)、肿瘤坏死因子-α(TNF-α)以及肝组织匀浆中内皮素-1(ET-1)的含量,免疫组化测定P-选择素的表达。结果肝脏缺血/再灌注后,病理有明显的损伤改变。PTX保护组再灌注2、4h血清ALT、LDH、TNF-α和肝组织匀浆中ET-1含量与对照组相比显著降低(P<0.01),PTX保护组P-选择素蛋白表达显著低于对照组(P<0.01)。结论肝脏微循环障碍是肝脏缺血/再灌注损伤的病理基础,给予PTX预处理可降低TNF-α、ET-1产生和减少P-选择素表达,从而减轻肝脏损伤。 Objective To investigate the effect of pentoxifylline(PTX) on hepatic ischemia and reperfusion injury in rats. Methods 64 healthy male SD rats were randomly divided into PTX pretreatment group and control group. Serum alanine aminotransferase(ALT), lactate dehydrogenase(LDH), tumor necrosis factor-a( TNF-α and endothelin-1 of liver tissue were determined at different times. The expression of P-selectin in the liver tissue was located and analyzed by immunohistoehemical staining. Results There was histologic evidence of liver injury. At 2h, 4h of reperfusion, ALT, LDH, TNF-α and ET-1 in control group decreased compared with PTX pretreatment group( P 〈 0.01), Moreover, P-selectin staining was attenuated in control group compared with PTX pretreatment group( P 〈 0.01 ). Conclusion Activation of ET and cytokines contribute to microcirculatory disturbance, which is pathologic procedure of hepatic ischemia and reperfusion. PTX pretreatment can reduce liver injury through reducing TNF-α, ET-1 production and P-selectin expression.
出处 《中国微循环》 2009年第2期99-101,114,F0002,共5页 Journal of Chinese Microcirculation
关键词 肝脏 缺血 再灌注损伤 Liver Ischemia Reperfusion injury
  • 相关文献

参考文献2

二级参考文献31

  • 1周同,王鸿利.细胞粘附分子、粘附蛋白与血栓形成[J].中华血液学杂志,1994,15(9):495-497. 被引量:6
  • 2Beckede MC. Cell adhesion[M] . Oxford: Oxford University Press.2002,1-36.
  • 3周同,吴佩.细胞黏附分子与血栓形成.见王鸿利,王学锋主编:血栓病临床新技术[M].第1版.北京:人民军医出版社.2003.67~80.
  • 4Klaus Ley. The role of selectin in inflammation and disease[J] .TRENDS in Molecular Medcine. 2003,9(6) : 263 -268.
  • 5Lowe JB. Selectin ligands, leukocyte trafficking, and fucosyl transferase genes[J], Kidney Int. 1997,51:1418-1426.
  • 6Li N, Hu H, Lindqvist M, et al. Platelet - leukocyte cross talk in whole blood[J]. Arterioscler Thromb Vasc Biol. 2000,20:2702 - 2708.
  • 7Wang JG, Mu JS, Zhu HS, et al. N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo[J] .Inflamm Res. 2002,51 (9) :435 -443.
  • 8Papalambros E, Sigala F, Travlou A, et al. P- selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment[J] . J Am Coil Surg. 2004, 199(1):69-77.
  • 9Blann AD, Lip GYH. Is soluble P - selectin a new marker of platelet activation[J]? Atherosclerosis. 1997, 128:135 - 138.
  • 10Merten M, Thiagarajan P. P - Selectin expression on platelets determines size and stability of platelet aggregates[J] . Circulation. 2000,102:1931 - 1936.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部